Segment Information (Tables)

12 Months Ended

Dec. 31, 2024

Segment Information [Abstract]

Schedule of Segment Information

Our chief operating decision-maker is our President and CEO.

	During the Year Ended December 31, 2024
	Scours		Mastitis			Other			Total
Product sales	$	26,314,251	$	178,918		$	—		$	26,493,169
Costs of goods sold		18,382,949		169,176			—			18,552,125
Gross margin		7,931,302		9,742			—			7,941,044
Product development expenses		243,578		3,493,298			161,706			3,898,582
Sales and marketing expenses		2,909,799		556,273			—			3,466,072
Administrative expenses		—		—			2,216,549			2,216,549
Operating expenses		3,153,377		4,049,571			2,378,255			9,581,203
NET OPERATING INCOME (LOSS)	$	4,777,925	$	(4,039,829	)	$	(2,378,255	)	$	(1,640,159	)

	During the Year Ended December 31, 2023
	Scours		Mastitis			Other			Total
Product sales	$	17,293,933	$	177,736		$	—		$	17,471,669
Costs of goods sold		13,453,514		148,871			—			13,602,385
Gross margin		3,840,419		28,865			—			3,869,284
Product development expenses		11,103		4,242,329			141,420			4,394,852
Sales and marketing expenses		2,447,137		641,078			—			3,088,215
Administrative expenses		—		—			2,134,295			2,134,295
Operating expenses		2,458,240		4,883,407			2,275,715			9,617,362
NET OPERATING INCOME (LOSS)	$	1,382,179	$	(4,854,542	)	$	(2,275,715	)	$	(5,748,078	)

	Scours		Mastitis		Other		Total
Total Assets as of December 31, 2024	$	24,644,294	$	16,523,048	$	3,933,135	$	45,100,477
Total Assets as of December 31, 2023	$	24,735,413	$	17,827,839	$	1,244,850	$	43,808,102
Depreciation and amortization expense during the year ended December 31, 2024	$	1,373,815	$	1,277,218	$	78,814	$	2,729,847
Depreciation and amortization expense during the year ended December 31, 2023	$	1,365,988	$	1,287,600	$	86,032	$	2,739,620
Capital Expenditures during the year ended December 31, 2024	$	409,696	$	53,721	$	2,308	$	465,725
Capital Expenditures during the year ended December 31, 2023	$	1,096,819	$	795,694	$	—	$	1,892,513